Month: August 2025

The leadership of Civinity, one of the largest groups in the Baltics providing building maintenance services and developing engineering and technology solutions, is undergoing a change. With CEO Virgeda Jackaitė going on maternity leave after more than two years at the helm, Tomas Staškūnas has been appointed Acting Chief Executive Officer. Virgeda Jackaitė has led Civinity since May 29, 2023. She is temporarily stepping down from her position as CEO to take maternity leave. As of August 27, the role of Chief Executive Officer is assumed on an interim basis by Tomas Staškūnas, who until now has served as the Group’s Chief Financial Officer. Tomas Staškūnas has more than 20 years of experience in finance, where he has held various leadership positions. For over twelve years, he headed the finance department of the Novaturas Group. Staškūnas...

IDEX Biometrics ASA’s first half 2025 report is attached to this notice. Recent highlights:Operating expenses excluding Cost of materials and Depreciation in the first six months of 2025 amounted to $5.2 million (excluding restructuring cost) compared to $10.7 million for the same period in 2024, resulting in a cost reduction of 52%, year-over-year At the end of the second quarter of 2025 the Company had 30 full-time equivalent staff members, a reduction of 10 full-time equivalents compared to previous quarter, and down from 59 on June 30, 2024. Resulted in a cost reduction in compensation and benefits of $1.9 million, 73%, compared to previous quarter, and a cost reduction of $4.1 million, 72%, year-over-year. Heights convertible bond renegotiated and amendedOutstanding principal reduced from approx. NOK66.6 million to approx....

Vivoryon Therapeutics N.V. to Report H1 2025 Financial Results and Operational Progress on September 4, 2025 Halle (Saale) / Munich, Germany, August 27, 2025 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company developing small molecule medicines for inflammatory and fibrotic disorders, with a primary focus on kidney diseases, today announced that it will publish its half year financial results for the period ended June 30, 2025 and provide a corporate update on Thursday, September 4, 2025. The Company will host a conference call and webcast open to the public. The report will be available for download on the Company’s website (https://www.vivoryon.com/financial-information/). Conference call detailsDate: September 4, 2025Time: 3:00 pm CEST / 9:00 am EDT The conference call...

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – August 27, 2025Idorsia Ltd (SIX: IDIA) settled the repurchase offer for its outstanding CHF 204* million convertible bonds maturing in 2025 (CB 2025; ISIN CH0426820350) and CHF 600 million convertible bonds maturing in 2028 (CB 2028; ISIN CH1128004079) launched on June 25, 2025 (the Repurchase Offer). Bondholders accepted the Repurchase Offer for the CB 2025 with an aggregate nominal value of CHF 187,476,000, corresponding to 91.90% of the total issued nominal value of the CB 2025, and for the CB 2028 with an aggregate nominal value of CHF 567,200,000, corresponding to 94.53% of the total issued nominal value of the CB 2028. The documentation in relation to the Repurchase Offer (the Repurchase Offer Documentation) can be found at the following link: www.idorsia.com/exchange-offer. For...

On 11 July 2025, Bigbank AS announced via a stock exchange notice the conclusion of intra-group merger agreement between Balti Võlgade Sissenõudmise Keskus OÜ (the company being acquired), a subsidiary of Bigbank AS, and OÜ Rüütli Property (the acquiring company), a subsidiary of OÜ Rüütli Majad which is a subsidiary of Bigbank AS.  Bigbank AS hereby announces that the merger was officially recorded in the Estonian commercial register on 26 August 2025. As a result, Balti Võlgade Sissenõudmise Keskus OÜ has been deleted from the commercial register as of 26 August 2025.  Bigbank AS (www.bigbank.eu), with over 30 years of operating history, is a commercial bank owned by Estonian capital. As of 31 July 2025, the bank’s total assets amounted to 3.1 billion euros, with equity of 284 million euros. Operating in nine countries, the bank...

MELBOURNE, Australia, Aug. 26, 2025 (GLOBE NEWSWIRE) — Immuron Limited (ASX: IMC; NASDAQ: IMRN) advises it has entered into a partnership with InvestorHub, a direct-to-investor engagement software company that provides public companies the digital capabilities to build direct and interactive relationships with investors. In line with the Company’s commitments to better inform and engage with investors and stakeholders, we have launched our interactive investor hub – bringing content and communication into a single integrated platform. The Company will also be regularly uploading new content via the hub, including videos accompanying select announcements, educational material, interviews and corporate research. Chief Executive Officer, Steven Lydeamore, commented: “With a number of near term milestones coming up, there has...

LA JOLLA, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), announces that it successfully achieved enrollment of the target number of participants in its COMBAT-ALS Phase 2b/3 clinical trial of MN-166 (ibudilast). MN-166 is currently in development for the treatment of Amyotrophic Lateral Sclerosis (ALS). Dr. Yuichi Iwaki, MediciNova President and CEO commented, “This milestone marks a significant step forward in the development of MN-166, reflecting strong collaboration among clinical sites, investigators, and patient communities. We are grateful to all the patients, their family, caregivers, investigators, and study teams whose dedication made this achievement possible....

– NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES –Non-Binding Indicative Term Sheet for a US$4,000,000 loan facility with Sprott Streaming over a 3-year maturity period for the Santa Cruz Graphite Mine in Brazil; The funds will be used to support the continued development and optimization of the Phase 1 Santa Cruz Graphite Mine in Brazil; and South Star and Sprott are working on the definitive documentation and expect the financing to close on an expediated schedule. Mr. Darren Prins has been appointed to the role of chief financial officer.VANCOUVER, British Columbia, Aug. 26, 2025 (GLOBE NEWSWIRE) — South Star Battery Metals Corp. (“South Star” or the “Company”) (TSXV: STS) (OTCQB: STSBF), is pleased to announce that it has signed a non-binding indicative term sheet (“Term Sheet”)...